{"schema_version":"secwatch.filing_event.v1","accession":"0001699350-26-000054","form_type":"8-K","ticker":"SI","cik":"0001699350","company_name":"SHOULDER INNOVATIONS, INC.","filed_at":"2026-08-10T11:09:48+00:00","discovered_at":"2026-08-10T11:15:00.278937+00:00","generated_at":"2026-08-10T11:15:25.488101+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Shoulder Innovations promotes Jon Osborne to Chief Commercial Officer","bullets":["Jon Osborne promoted to Chief Commercial Officer, effective Aug 6, 2026; previously VP of Commercial Development.","Osborne joined Shoulder Innovations in Sept 2023; prior 9 years at Smith & Nephew, most recently VP Commercial Marketing for Sports Medicine.","New role covers all commercial organization, customer experience, and medical education teams.","CEO Rob Ball cites Osborne's role in go-to-market strategy and scaling adoption."],"urls":{"canonical":"https://secwatch.observer/filing/0001699350-26-000054","json":"https://secwatch.observer/filing/0001699350-26-000054.json","markdown":"https://secwatch.observer/filing/0001699350-26-000054.md","text":"https://secwatch.observer/filing/0001699350-26-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/0001699350-26-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/si-20260810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T11:15:25.488101+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}